Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Palo Alto, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Eiger BioPharmaceuticals, Inc. has filed 694 SEC EDGAR filings since 05 Oct 2004

SEC filing history

Showing 351-375 of 687 matching filings.

Per page
25
Current page
15
8-K File 001-36183

FORM 8-K

Filing date
22 Feb 2018
Reporting date
22 Feb 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87931

SC 13G/A

Filing date
14 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87931

SC 13G/A

Filing date
13 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87931

SC 13G/A

Filing date
13 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87931

13G INITIAL ANNUAL FILING - EIGR

Filing date
05 Feb 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87931

SC 13G filing

Filing date
19 Jan 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

FORM 8-K

Filing date
18 Jan 2018
Reporting date
16 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Jan 2018
Reporting date
05 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
09 Jan 2018
Reporting date
05 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Jan 2018
Reporting date
05 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

FORM 8-K

Filing date
08 Jan 2018
Reporting date
08 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-221972

EFFECT filing

Filing date
20 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
15 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
15 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-221972

REGISTRATION STATEMENT ON FORM S-3

Filing date
08 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

8-K

Filing date
09 Nov 2017
Reporting date
09 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87931

SCHEDULE 13G

Filing date
09 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-87931

SC 13D/A

Filing date
01 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-212114

PROSPECTUS SUPPLEMENT FILED PURSUANT TO RULE 424(B)(5)

Filing date
30 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

FORM 8-K

Filing date
30 Oct 2017
Reporting date
27 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-212114

PROSPECTUS SUPPLEMENT FILED PURSUANT TO RULE 424(B)(5)

Filing date
26 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36183

FORM 8-K

Filing date
23 Oct 2017
Reporting date
23 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Oct 2017
Reporting date
28 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .